MB-CART2219.1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MB-CART2219.1, covering 2025-08-07 to 2025-08-07. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Dose Finding Study of MB-CART2219.1 [Phase 1]